|
⚲
|
| NCTI II LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001478673 |
| Sale | 2009-12-11 ($5.0 M Offered, $1.0 M Sold) |
| Fund | |
| Phone | 7346627667 |
| Address | 206 S Fifth Ave, Suite 550 Ann Arbor, 48104 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Lindsay Aspegren | |
| General Partner Nc Management LLC | |
| Hugo Braun |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
JE Fund I, a series of Unpopular VC, LP
✚
|
0.0 | |
|
JE Fund II, a series of Unpopular VC, LP
✚
|
0.0 | |
|
Jeifetz Martha V.
✚
|
0.0 | |
|
JEM Ventures Series 1
✚
|
0.0 | |
|
JEM Ventures Series 2
✚
|
0.0 | |
|
Jengu Therapeutics, Inc.
✚
|
0.0 | |
|
Jenkins David H
✚
|
0.0 | |
|
Jenkin Thomas M
✚
|
0.0 | |
|
Jennings Kevin
✚
|
0.0 | |
|
Jedar Capital Cohort 16, a Series of Assure Labs 2022, LLC
✚
|
0.0 |